CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Methylprednisolone sodium succinatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00290602
NCT00290602Phase 2Completed
CompareCT.gov

Prospective Phase II Study of Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome (ARDS) After Thoracic Surgery (E-START)

National Cancer Center, Korea·interventional·Posted Feb 13, 2006·Updated Jan 17, 2007

In Brief

A Phase 2 clinical trial evaluating Methylprednisolone sodium succinate for Acute Respiratory Distress Syndrome and 2 related conditions. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine whether the 2mg/kg administration of corticosteroids, in the form of methylprednisolone sodium succinate, in early phase acute respiratory distress syndrome after thoracic surgery, will reduce the postoperative mortality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Respiratory Distress Syndrome, Acute Lung Injury, Postoperative Complications
CountriesSouth Korea
Collaborators--

Timeline

Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 13, 2006
Enrollment StartFeb 1, 2004
Study CompletionDec 1, 2006
TodayJul 2, 2026
Posted 20.4 years ago

Interventions

Methylprednisolone sodium succinatedrug